Assessing The Risks In Pausing The Johnson & Johnson Vaccine
The pause in the use of Johnson & Johnson’s Covid-19 vaccine may continue for a week to 10 days - after expert advisers to the CDC said they needed more time to assess a possible link to a rare but serious blood-clotting disorder.
On this edition of River to River, host Ben Kieffer speaks with hospital epidemiologist at the University of Iowa Dr. Jorge Salinas about the pause in shots of the Johnson & Johnson vaccine. Health reporters Michaela Ramm of the Cedar Rapids Gazette and Natalie Krebs of Iowa Public Radio also join the program for their perspectives on the pandemic and the vaccination campaign.
- Jorge Salinas, hospital epidemiologist, Carver College of Medicine, University of Iowa
- Michaela Ramm, health reporter, Cedar Rapids Gazette
- Natalie Krebs, health reporter, Iowa Public Radio